nivolumab,aldesleukin,cabozantinib,sunitinib,bempegaldesleukin
clinigen,exelixis,pfizer,bms,prometheus,novartis,nektar
['nivo', 'sunitinib', 'bempeg', 'cabozantinib', 'rcc,(-irccs),(-srcc),(-urcc)', 'aldesleukin', 'nivolumab']
bempegaldesleukin + nivolumab compared to the investigator s choice of sunitinib or cabozantinib in previously untreated advanced #rcc, results from a phase 3 randomized study. presented by nizar tannir, md . #esmo22 &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology